soon-to-launch
Aug 6, 2026
This survey will be a cross-sectional descriptive survey of the knowledge, views, and experiences concerning medications for HIV prevention (PrEP), particularly focusing on lenacapavir, among NYC women who have risk factors for the acquisition of HIV....
Aug 6, 2026
This multicenter randomized clinical trial will test a suite of mHealth tools to increase the use of medication to prevent HIV (PrEP) and improve adherence to PrEP among young men in communities most affected by the HIV epidemic and evaluate the uptake, adherence, and...
Jul 29, 2026
This study looks at doxycycline, a well-known antibiotic that is commonly used to prevent and treat acne and some sexually transmitted infections (STIs) like gonorrhea, chlamydia, and syphilis, to learn if taking doxycycline either after condomless sex (known as...
Mar 6, 2024
The HIV differentiated service delivery (DSD) strategic initiative (SI) provided technical assistance (TA) to address gaps in testing and treatment for key populations, men, adolescents, and children. The role of the initiative is catalytic to the new HIV grants,...
Apr 4, 2023
A Randomized Non-Inferiority Study to Assess Immunogenicity, Safety, and Acceptability of Two vs. Three Doses of the Nonavalent Human Papillomavirus (HPV) Vaccine Among Children, Adolescents and Young Adults Living with HIV in...